Approaches to handling pharmacodynamic baseline responses

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 35, Issue 3, 2008, Pages 269-283

  Dansirikul, Chantaratsamon ^a   Silber, Hanna E ^a   Karlsson, Mats O ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Baseline model; Baseline responses; Pharmacodynamics; Pharmacokinetics

Indexed keywords

ACCURACY; ANALYTICAL ERROR; ARTICLE; CALCULATION; COVARIANCE; EVALUATION; MODEL; MONTE CARLO METHOD; PARAMETER; PERFORMANCE; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL;

ALGORITHMS; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; HUMANS; MODELS, STATISTICAL; MONTE CARLO METHOD; PHARMACOKINETICS; POPULATION; REFERENCE VALUES;

EID: 47149107776     PISSN: 1567567X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10928-008-9088-2     Document Type: Article

References (17)

1. Aarons L, Baxter C, Gupta S (2004) Pharmacodynamics of controlled release verapamil in patients with hypertension: an analysis using spline functions. Biopharm Drug Dispos 25: 219-225
2. Comets E, Mentre F, Grass P, Kawai R, Marbach P, Vonderscher J (2003) Population pharmacodynamic analysis of octreotide in acromegalic patients. Clin Pharmacol Ther 73: 95-106
3. Furuya A, Nozawa M, Gotoh J, Jingu S, Akimoto M, Higuchi S, Suwa T, Ogata H (2002) Pharmacokinetic and pharmacodynamic analysis of TS-943, a selective non-peptide platelet glycoprotein-IIb/IIIa (GPIIb/IIIa) receptor antagonist, using a nonlinear mixed effect model in dogs. J Pharm Pharmacol 54: 921-927
4. Hugh BM, Frey N (2004) Population PK and PK/PD analyses of an enzyme inhibitor in healthy volunteers. In: PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe, Sweden
5. Karlsson MO, Wade JR, Loumaye E, Munafo A (1998) The population pharmacokinetics of recombinant- and urinary-human follicle stimulating hormone in women. Br J Clin Pharmacol 45: 13-20
6. Liesenfeld K, Stangier J, Garnett C, Tillmann C, Troconiz I, Lee H, Schaefer H (2005) PK/PD-modeling (PK/PD) and clinical trial simulation (CTS) of early clinical data of a new oral direct thrombin inhibitor (Dabigatran Etexilate). In: PAGE: Abstracts of the Annual Meeting of the Population Approach Group in Europe, Spain
7. Ramakrishnan R, Cheung WK, Wacholtz MC, Minton N, Jusko WJ (2004) Pharmacokinetic and pharmacodynamic modeling of recombinant human erythropoietin after single and multiple doses in healthy volunteers. J Clin Pharmacol 44: 991-1002
8. Togawa A, Tanaka T, Nagashima S, Keta H, Kobayashi Y, Nishikawa Y, Yanai M, Tanaka H (2004) A comparison of the bioequivalence of two formulations of epoetin alfa after subcutaneous injection. Br J Clin Pharmacol 58: 269-276
9. Zingmark PH, Edenius C, Karlsson MO (2004) Pharmacokinetic/ pharmacodynamic models for the depletion of V(beta)5.2/5.3 T cells by the monoclonal antibody ATM-027 in patients with multiple sclerosis, as measured by FACS. Br J Clin Pharmacol 58: 378-389
10. Silber HE, Jauslin PM, Frey N, Gieschke R, Simonsson US, Karlsson MO (2007) An integrated model for glucose and insulin regulation in healthy volunteers and type 2 diabetic patients following intravenous glucose provocations. J Clin Pharmacol 47: 1159-1171
11. Sheiner LB (2003) NONMEM Tips #16 - April 2, 2003 - Modeling a "baseline" component and an additive "drug" component. http://www.huxley.phor.com/nonmem/nm/99apr022003.html. Accessed 13 Jan 2006
12. Mordenti J, Cavagnaro JA, Green JD (1996) Design of biological equivalence programs for therapeutic biotechnology products in clinical development: a perspective. Pharm Res 13: 1427-1437
13. Schindel F (2000) Consideration of endogenous backgrounds in pharmacokinetic analyses: a simulation study. Eur J Clin Pharmacol 56: 685-688
14. Sun YN, Jusko WJ (1999) Role of baseline parameters in determining indirect pharmacodynamic responses. J Pharm Sci 88: 987-990
15. Beal SL, Sheiner LS (1994) NONMEM user's guide. San Fransisco: NONMEM project group. University of California at San Fransisco
16. Lindbom L, Pihlgren P, Jonsson EN (2005) PsN-Toolkit-a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed 79: 241-257
17. Dayneka NL, Garg V, Jusko WJ (1993) Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm 21: 457-478